Star Health and Allied Insurance Company Limited (NSE:STARHEALTH)
India · Delayed Price · Currency is INR 610.40
+11.55 (1.93%)
Jul 30, 2026, 3:30 PM IST
NSE:STARHEALTH Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Premiums & Annuity Revenue | 171,775 | 165,967 | 148,222 | 129,383 | 112,616 | 98,092 |
Total Interest & Dividend Income | 12,887 | 12,283 | 9,914 | 9,256 | 8,233 | 6,305 |
Gain (Loss) on Sale of Investments | - | - | 2,877 | 1,575 | 112.35 | 1,623 |
Other Revenue | 83.8 | 83.8 | 92.3 | 37.4 | 38.6 | 13.71 |
| 184,745 | 178,334 | 161,105 | 140,251 | 121,000 | 106,034 | |
Revenue Growth | 15.18% | 10.69% | 14.87% | 15.91% | 14.12% | 109.94% |
Policy Benefits | 117,222 | 113,752 | 104,194 | 85,940 | 73,204 | 85,400 |
Policy Acquisition & Underwriting Costs | 27,352 | 26,733 | 22,407 | 18,596 | 16,828 | 14,922 |
Selling, General & Administrative | 3,623 | 3,623 | 25,243 | 23,604 | 20,310 | 18,221 |
Provision for Bad Debts | 3.2 | 3.2 | 4.8 | 25.1 | 10.96 | 26.17 |
Other Operating Expenses | 7,118 | 6,858 | -4.4 | -17.7 | -9.44 | - |
Total Operating Expenses | 175,695 | 170,801 | 151,846 | 128,157 | 111,850 | 119,323 |
Operating Income | 9,050 | 7,533 | 9,259 | 12,094 | 9,150 | -13,289 |
Interest Expense | - | - | -654.2 | -801.4 | -884.19 | -720.06 |
Currency Exchange Gain (Loss) | 10.1 | 10.1 | 8.3 | - | - | - |
Other Non Operating Income (Expenses) | 0.4 | 0.1 | 3.5 | -2.4 | 0.41 | 56.72 |
EBT Excluding Unusual Items | 9,074 | 7,543 | 8,616 | 11,290 | 8,267 | -13,953 |
Gain (Loss) on Sale of Assets | - | - | -5.8 | -1.8 | -2.47 | -13.63 |
Pretax Income | 9,079 | 7,543 | 8,611 | 11,289 | 8,264 | -13,966 |
Income Tax Expense | 2,394 | 1,973 | 2,152 | 2,838 | 2,078 | -3,560 |
Net Income | 6,685 | 5,570 | 6,459 | 8,450 | 6,186 | -10,407 |
Net Income to Common | 6,685 | 5,570 | 6,459 | 8,450 | 6,186 | -10,407 |
Net Income Growth | 13.41% | -13.76% | -23.57% | 36.60% | - | - |
Shares Outstanding (Basic) | 588 | 588 | 587 | 583 | 578 | 558 |
Shares Outstanding (Diluted) | 588 | 588 | 595 | 596 | 594 | 558 |
Shares Change | -0.71% | -1.10% | -0.14% | 0.21% | 6.50% | 11.78% |
EPS (Basic) | 11.36 | 9.47 | 11.01 | 14.48 | 10.70 | -18.65 |
EPS (Diluted) | 11.36 | 9.47 | 10.86 | 14.19 | 10.41 | -18.65 |
EPS Growth | 14.23% | -12.80% | -23.47% | 36.31% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | - | 12,959 | 11,865 | 12,292 | -75.67 |
Free Cash Flow Per Share | - | - | 21.79 | 19.92 | 20.68 | -0.14 |
Operating Margin | 4.90% | 4.22% | 5.75% | 8.62% | 7.56% | -12.53% |
Profit Margin | 3.62% | 3.12% | 4.01% | 6.02% | 5.11% | -9.81% |
Free Cash Flow Margin | - | - | 8.04% | 8.46% | 10.16% | -0.07% |
EBITDA | - | 7,843 | 9,569 | 12,681 | 9,671 | -12,856 |
EBITDA Margin | - | 4.40% | 5.94% | 9.04% | 7.99% | -12.13% |
D&A For EBITDA | - | 310.4 | 310.4 | 587.1 | 520.67 | 432.99 |
EBIT | 9,050 | 7,533 | 9,259 | 12,094 | 9,150 | -13,289 |
EBIT Margin | 4.90% | 4.22% | 5.75% | 8.62% | 7.56% | -12.53% |
Effective Tax Rate | 26.37% | 26.16% | 24.99% | 25.14% | 25.15% | - |